Page last updated: 2024-09-04

tipifarnib and lanosterol

tipifarnib has been researched along with lanosterol in 1 studies

Compound Research Comparison

Studies (tipifarnib)	Trials (tipifarnib)	Recent Studies (post-2010) (tipifarnib)	Studies (lanosterol)	Trials (lanosterol)	Recent Studies (post-2010) (lanosterol)
309	92	94	1,010	8	335

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Buckner, FS; Gelb, MH; Hucke, O; Verlinde, CL	1

Other Studies

1 other study(ies) available for tipifarnib and lanosterol

Article	Year
The protein farnesyltransferase inhibitor Tipifarnib as a new lead for the development of drugs against Chagas disease. Journal of medicinal chemistry, 2005, Aug-25, Volume: 48, Issue:17 Topics: Alkyl and Aryl Transferases; Animals; Binding Sites; Chagas Disease; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Humans; Lanosterol; Models, Molecular; Oxidoreductases; Protein Binding; Quinolones; Sterol 14-Demethylase; Structure-Activity Relationship; Trypanocidal Agents; Trypanosoma cruzi	2005

Article

Year

The protein farnesyltransferase inhibitor Tipifarnib as a new lead for the development of drugs against Chagas disease.

Journal of medicinal chemistry, 2005, Aug-25, Volume: 48, Issue:17

Topics: Alkyl and Aryl Transferases; Animals; Binding Sites; Chagas Disease; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Humans; Lanosterol; Models, Molecular; Oxidoreductases; Protein Binding; Quinolones; Sterol 14-Demethylase; Structure-Activity Relationship; Trypanocidal Agents; Trypanosoma cruzi

2005